CDK 4/6 Inhibitors in Metastatic Breast Cancer

1 意见
administrator
administrator
07/03/23

Hope S. Rugo, MD, discusses the use of CDK 4/6 inhibitors and their impact on the treatment paradigm for metastatic breast cancer.

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个